Frankfurt - Delayed Quote EUR

Zimmer Biomet Holdings, Inc. (ZIM.F)

105.55

+2.35

+(2.28%)

At close: January 17 at 8:00:12 AM GMT+1

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

PR Newswire 3 days ago

ZBH
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. (ZBH) on Business Model Mastery’s Substack by The Antifragile Investor. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc. (ZBH)’s share was trading at $104.71 as of Jan 14th. ZBH’s trailing and forward P/E were 19.98 and 12.22 respectively […]

Insider Monkey 3 days ago

ZBH
JP Morgan 2025: Zimmer Biomet bullish on a strong market return in 2025

Zimmer Biomet anticipates that six products launched last year will come into their own throughout 2025.

Medical Device Network 4 days ago

ZBH
Should You Consider Retaining ZBH Stock in Your Portfolio Now?

Zimmer Biomet's robust efforts to expand the Knee business and a gradually stabilizing musculoskeletal market appear promising.

Zacks 5 days ago

ZBH
Zimmer Biomet price target raised to $113 from $110 at Evercore ISI

Evercore ISI raised the firm’s price target on Zimmer Biomet (ZBH) to $113 from $110 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source for

TipRanks 16 days ago

ZBH
Zimmer Biomet: The Valuation Discount Is Not Justified

Zimmer Biomet's business turnaround has not been recognized by the market

GuruFocus.com 23 days ago

ZBH

SYK
ZBH Stock to Benefit From Global Expansion Despite Macro Issues

Zimmer Biomet is witnessing strong market share gains within reconstructive Knees and Hips in key geographies despite macroeconomic challenges.

Zacks 24 days ago

ZBH
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 8:15 a.m. PT (11:15 a.m. ET).

PR Newswire 30 days ago

ZBH
Zimmer Biomet price target raised to $118 from $117 at Truist

Truist raised the firm’s price target on Zimmer Biomet (ZBH) to $118 from $117 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as “one of the better/safer houses” in healthcare given its lower “front-line” exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an “innovation segment” with sustainable above-average revenue and EPS growth, strong balance she

TipRanks last month

ZBH
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...

Despite a challenging quarter, NeuroOne Medical Technologies Corp (NMTC) anticipates robust revenue growth in 2025, driven by new FDA approvals and strategic alliances.

GuruFocus.com last month

ZBH
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago

Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...

Simply Wall St. last month

ZBH
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024.

PR Newswire last month

ZBH
Q4 2024 Neuroone Medical Technologies Corp Earnings Call

Q4 2024 Neuroone Medical Technologies Corp Earnings Call

Thomson Reuters StreetEvents last month

ZBH
Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls

Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls

The Fly last month

TSLA

ECL

GLOB
ZBH Stock Might Rise Following FDA Nod for OsseoFit

Zimmer Biomet's OsseoFit Stemless Shoulder System gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.

Zacks last month

ZBH

RMD
Zimmer receives FDA nod for stemless shoulder implant

The Osseofit devices are intended to match patients’ shoulder bone anatomy and preserve healthy bone in total shoulder replacement procedures.

MedTech Dive last month

ZBH
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance

The commercial availability of the system is expected in the first quarter of next year.

Medical Device Network last month

ZBH
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the OsseoFit™ Stemless Shoulder System for total shoulder replacement. This innovative implant is designed to match the natural humeral (upper shoulder bone) anatomy1-3 to optimize anatomical fit while maximizing preservation of healthy bone. The OsseoFit Stemless Shoulder System expands the company's expansive total shoulder portfolio

PR Newswire last month

ZBH
Why Is Zimmer Biomet Holdings Inc. (ZBH) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where Zimmer Biomet Holdings Inc. (NYSE:ZBH) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry […]

Insider Monkey last month

ZBH
Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

PRGO

ZBH

Performance Overview

Return	ZIM.F	S&P 500
YTD	+3.63%	+1.52%
1-Year	-5.01%	+25.82%
3-Year	+0.23%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Zimmer Biomet Holdings, Inc. (ZIM.F)

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results

Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory

JP Morgan 2025: Zimmer Biomet bullish on a strong market return in 2025

Should You Consider Retaining ZBH Stock in Your Portfolio Now?

Zimmer Biomet price target raised to $113 from $110 at Evercore ISI

Zimmer Biomet: The Valuation Discount Is Not Justified

ZBH Stock to Benefit From Global Expansion Despite Macro Issues

Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Zimmer Biomet price target raised to $118 from $117 at Truist

NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...

Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024

Q4 2024 Neuroone Medical Technologies Corp Earnings Call

Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Zimmer receives FDA nod for stemless shoulder implant

Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance

Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement

Why Is Zimmer Biomet Holdings Inc. (ZBH) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?

Performance Overview